This segment brings together two essential threads — the broader context of lorlatinib's remarkable durability relative to ...

Kutscher says MDVIP is expanding into specialty care and eyeing pediatrics. Your browser does not support the audio element.

This segment addresses one of the most practically important aspects of lorlatinib therapy — its distinct and manageable ...

Hofstra University and Northwell Health’s jointly founded medical school has secured funding from the National Institutes of ...

Positive symptoms correlated with more negative sentiment and longer utterances, whereas negative symptoms aligned with ...

Skinvive by Juvéderm recently received FDA approval as the first hyaluronic acid injectable indicated for reducing horizontal ...

Thomas Martens, M.D., explains what drives adoption and how CONNECT's Level A evidence could move CGM coverage. New evidence ...

He also compared CGM directly to drug therapy: an SGLT2 inhibitor might lower A1C about 0.7%, while GLP-1 therapy can deliver ...

LucyRx and Abarca, two midsize pharmacy benefit managers, have agreed to merge to become one company that provides ...

Multidimensional assessment reframes pain around functional domains, including mood, activity, sleep, self-care, and ability ...

The healthcare industry succeeded in making behavioral healthcare more accessible, argues Machinify's Lisa Pincher. Now, it must build the infrastructure to support that care responsibly. What happens ...

Lung cancer has shifted from a rare, smoking-driven disease to one increasingly seen in young non-smokers, especially women, with possible links to pesticide exposure from otherwise “healthy” diets.